To determine the stage of amyloidosis, doctors use various staging systems based on the type of amyloidosis and the affected organs. Here are some key points from the knowledge base:

- AL Amyloidosis (Amyloid Light-Chain)
- Heart Staging: Uses biomarkers like NT-proBNP and cardiac troponin T to assess heart damage.
- read more

To determine the stage of amyloidosis, doctors use various staging systems based on the type of amyloidosis and the affected organs. Here are some key points from the knowledge base:

- AL Amyloidosis (Amyloid Light-Chain):
- Heart Staging: Uses biomarkers like NT-proBNP and cardiac troponin T to assess heart damage.
- Kidney Staging: Uses eGFR and proteinuria levels to assess kidney function.

- ATTR Amyloidosis (Transthyretin):
- Hereditary and Wild-Type: Staging considers biomarkers related to heart and kidney damage.

Doctors may recommend tests to measure these biomarkers through blood or urine tests to determine the stage and estimate the prognosis.

 This AI-generated response comes from MyAmyloidosisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Stages of Amyloidosis | MyAmyloidosisTeam

Staging and Progression of AL Amyloidosis | MyAmyloidosisTeam